Evaluating the Cost-Effectiveness of Endobronchial Ultrasound for Novice Practitioners: Insights from a Single-Center Learning Curve Study - Report - MDSpire

Evaluating the Cost-Effectiveness of Endobronchial Ultrasound for Novice Practitioners: Insights from a Single-Center Learning Curve Study

  • By

  • Oğuzhan Turan

  • Mehmet Akif Ekici

  • Bayram Metin

  • İbrahim Ethem Özsoy

  • Mehmet Akif Tezcan

  • Ömer Faruk Demir

  • October 29, 2025

  • 0 min

Share

Clinical Report: Evaluating Cost-Effectiveness of EBUS for Novice Practitioners

Overview

This study assesses the learning curve and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) performed by novice practitioners. Results indicate that EBUS-TBNA is a cost-effective alternative to conventional methods, with proficiency achieved after a defined number of procedures.

Background

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has revolutionized the approach to mediastinal lymph node sampling, particularly in lung cancer diagnostics. Traditional methods like mediastinoscopy have limitations in accessing certain lymph node stations, making EBUS-TBNA a valuable tool. Understanding the learning curve and cost implications of EBUS-TBNA is crucial for its integration into clinical practice, especially for novice practitioners.

Data Highlights

No numerical data available in the provided material.

Key Findings

  • EBUS-TBNA demonstrated a specificity of 100% for detecting mediastinal lymph node metastasis.
  • Approximately 40 procedures are required for novice practitioners to achieve proficiency in EBUS-TBNA.
  • Cost analysis showed significant savings when using EBUS-TBNA compared to conventional methods.
  • Accidental scope damage due to improper technique occurred in 1.33% of cases.
  • Training and certification significantly impacted the learning curve and cost outcomes.

Clinical Implications

The findings suggest that EBUS-TBNA can be effectively integrated into clinical practice for novice practitioners following structured training. The cost-effectiveness of EBUS-TBNA compared to traditional methods may lead to broader adoption, improving patient access to advanced diagnostic techniques.

Conclusion

EBUS-TBNA presents a cost-effective and efficient alternative for mediastinal sampling, particularly when practitioners undergo proper training. Continued evaluation of its implementation in clinical settings is warranted.

References

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. The ASCO Post, 2025 -- New Guidelines on Comprehensive Biomarker Testing of Bronchoscopic Biopsies
  5. American College of Chest Physicians, Interventional Pulmonary, 2024 -- EBUS transbronchial needle samples
  6. Author(s)/Org, Source, Year -- Full article: Endobronchial ultrasound-guided mediastinal biopsies for the diagnosis of mediastinal diseases: A network meta-analysis
  7. National Institute for Health and Care -- Effectiveness of nonultrasound-guided TBNA, EBUS-TBNA, or EUS-FNA for people with a probability of mediastinal malignancy
  8. EBUS transbronchial needle samples | Interventional Pulmonary - American College of Chest Physicians
  9. Full article: Endobronchial ultrasound-guided mediastinal biopsies for the diagnosis of mediastinal diseases: A network meta-analysis
  10. National Institute for Health and Care

Original Source(s)

Related Content